Breast Cancer Models

150+ models in China Biobank, 174 in US Biobank. Multiple subtypes: ER+, HER2+, TNBC.

PDO 1.0 & 2.0

H&E, IHC (ER, PR, HER2), WES

Validated Applications:

  • Subtype-specific drug efficacy
  • ADC evaluation
  • Biomarker discovery